Janice Chen cofounded Mammoth Biosciences straight out of Jennifer Doudna's lab — and she's been rewriting the CRISPR playbook ever since.

In this episode, she tells host and Benchling CEO Sajith Wickramasekara about what it really takes to build a platform company, why the biggest barriers to gene editing aren't scientific, and how a cruise ship outbreak in Oakland sparked a race to build a COVID test in days.